Clinical Oncology
Volume 18, Issue 6 , Pages 453-458 , August 2006

Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

  • M.J. Beresford

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • Corresponding Author InformationAuthor for correspondence: Mark Beresford, Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK. Tel: +44-1923-826111.
    • ,
  • R. Burcombe

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • ,
  • M.-L. Ah-See

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • ,
  • D. Stott

      Affiliations

    • Health Research Development and Support Unit (HRDSU), University of Hertfordshire, Hatfield, UK
    • ,
  • A. Makris

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK

Received 13 December 2005 ,Revised 22 March 2006 ,Accepted 10 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(06)00161-0

doi: 10.1016/j.clon.2006.04.006

Clinical Oncology
Volume 18, Issue 6 , Pages 453-458 , August 2006

Article Tools

* Image Usage & Resolution